Rothschild Capital Partners LLC increased its position in shares of Xylem Inc. (NYSE:XYL) by 85.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 111,712 shares of the company’s stock after buying an additional 51,502 shares during the period. Xylem accounts for about 2.6% of Rothschild Capital Partners LLC’s investment portfolio, making the stock its 20th largest position. Rothschild Capital Partners LLC’s holdings in Xylem were worth $4,988,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of the stock. Ngam Advisors L.P. boosted its stake in Xylem by 3.7% in the first quarter. Ngam Advisors L.P. now owns 17,552 shares of the company’s stock worth $718,000 after buying an additional 629 shares during the last quarter. Pacad Investment Ltd. bought a new stake in Xylem during the first quarter worth about $249,000. Virginia Retirement System bought a new stake in Xylem during the first quarter worth about $360,000. Nisa Investment Advisors L.L.C. boosted its stake in Xylem by 10.9% in the first quarter. Nisa Investment Advisors L.L.C. now owns 50,771 shares of the company’s stock worth $2,077,000 after buying an additional 5,000 shares during the last quarter. Finally, Aperio Group LLC boosted its stake in Xylem by 12.1% in the first quarter. Aperio Group LLC now owns 116,622 shares of the company’s stock worth $4,770,000 after buying an additional 12,566 shares during the last quarter. Institutional investors own 84.72% of the company’s stock.

Shares of Xylem Inc. (NYSE:XYL) traded up 0.42% during trading on Tuesday, reaching $50.74. The company had a trading volume of 724,244 shares. The company has a 50 day moving average of $49.66 and a 200-day moving average of $44.94. The firm has a market capitalization of $9.09 billion, a P/E ratio of 27.09 and a beta of 1.15. Xylem Inc. has a 52-week low of $31.27 and a 52-week high of $51.79.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, beating analysts’ consensus estimates of $0.47 by $0.01. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The firm had revenue of $932 million for the quarter, compared to analysts’ expectations of $927.69 million. During the same period in the prior year, the business posted $0.43 earnings per share. The business’s revenue was up 1.3% compared to the same quarter last year. Equities analysts expect that Xylem Inc. will post $2.04 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 21st. Shareholders of record on Wednesday, August 31st will be given a $0.1549 dividend. This represents a $0.62 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend is Monday, August 29th. Xylem’s dividend payout ratio (DPR) is 33.16%.

A number of equities research analysts have issued reports on the company. Atlantic Securities upgraded Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 target price on the stock in a research note on Monday, August 22nd. RBC Capital Markets set a $51.00 target price on Xylem and gave the company a “buy” rating in a research note on Tuesday, August 16th. Royal Bank Of Canada raised their target price on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a research note on Tuesday, August 16th. Canaccord Genuity reiterated a “hold” rating and issued a $50.00 target price (up from $45.00) on shares of Xylem in a research note on Tuesday, August 16th. Finally, Barclays PLC raised their target price on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a research note on Monday, July 18th. Nine research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Xylem currently has a consensus rating of “Hold” and a consensus price target of $45.00.

In other Xylem news, insider Colin R. Sabol sold 27,473 shares of the business’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total value of $1,398,650.43. Following the transaction, the insider now owns 65,530 shares of the company’s stock, valued at $3,336,132.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Tomas Brannemo sold 8,524 shares of the business’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $50.06, for a total value of $426,711.44. The disclosure for this sale can be found here. 0.77% of the stock is owned by company insiders.

About Xylem

Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

5 Day Chart for NYSE:XYL

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.